
A sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method utilizing immunoaffinity enrichment to has been developed to quantify donanemab, an Alzheimer’s therapy, in human serum. The process involves immunoaffinity capture followed by tryptic digestion and targeted peptide quantification, and provides a robust, high-precision alternative to traditional immunoassays for monitoring therapeutic monoclonal antibodies in clinical settings.





























